Teva Pharmaceutical Industries (TEVA) Intangibles (2016 - 2025)
Historic Intangibles for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $3.8 billion.
- Teva Pharmaceutical Industries' Intangibles fell 1441.83% to $3.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.8 billion, marking a year-over-year decrease of 1441.83%. This contributed to the annual value of $3.8 billion for FY2025, which is 1441.83% down from last year.
- Latest data reveals that Teva Pharmaceutical Industries reported Intangibles of $3.8 billion as of Q4 2025, which was down 1441.83% from $3.9 billion recorded in Q3 2025.
- Over the past 5 years, Teva Pharmaceutical Industries' Intangibles peaked at $8.4 billion during Q1 2021, and registered a low of $3.8 billion during Q4 2025.
- Over the past 5 years, Teva Pharmaceutical Industries' median Intangibles value was $5.6 billion (recorded in 2023), while the average stood at $5.8 billion.
- As far as peak fluctuations go, Teva Pharmaceutical Industries' Intangibles tumbled by 1837.33% in 2022, and later crashed by 1357.74% in 2023.
- Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Intangibles stood at $7.5 billion in 2021, then decreased by 16.02% to $6.3 billion in 2022, then decreased by 14.08% to $5.4 billion in 2023, then decreased by 17.99% to $4.4 billion in 2024, then fell by 14.42% to $3.8 billion in 2025.
- Its Intangibles was $3.8 billion in Q4 2025, compared to $3.9 billion in Q3 2025 and $4.1 billion in Q2 2025.